S16--Year(s) in Review

Friday, September 27, 2024

2:30 PM – 4:30 PM ET

Location:258 A-C

Chair(s)

Pierre-Régis Burgel, MD, PhD (he/him/his)

Hôpital Cochin
Assistance Publique Hopitaux de Paris and Université de Paris
Ranjani Somayaji, MD, MPH, FRCPC (she/her/hers)

Department of Microbiology, Immunology and Infectious Diseases
University of Calgary

The session will provide a high-level overview on contemporary and relevant topics in cystic fibrosis including use of artificial intelligence in diagnostics, vaccine advancements, mental health considerations with therapeutic shifts, and results from key and upcoming clinical trials.

Learning Objectives:

Describe the evolving technologies in imaging diagnostics including relevant applications in cystic fibrosis.
Discuss the shifting focus to mental health and vaccine strategies in the face of improved longevity and therapeutic advancements.
Outline key findings of large clinical trial efforts in cystic fibrosis.

Presentations:

2:30 PM – 4:30 PM ET

S16.1- Imaging & Artificial Intelligence
Speaker: Guillaume Chassagnon, MD, PhD (he/him/his) – Hopital Cochin
2:30 PM – 4:30 PM ET

S16.2- Mental Health After ETI
Speaker: Sophie Corriveau, MD, FRCPC – McMaster University
2:30 PM – 4:30 PM ET

S16.3- Vaccines in Cystic Fibrosis
Speaker: Rafael Hernandez – Seattle Children's & Univ of WA
2:30 PM – 4:30 PM ET

S16.4- Clinical Trial Updates
Speaker: Damian Downey, MD – Wellcome-Wolfson Institute for Experimental Medicine, Queens University Belfast, Northern Ireland